Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Abstract We sought to establish a large animal model of inherited hypertrophic cardiomyopathy (HCM) with sufficient disease severity and early penetrance for identification of novel therapeutic strategies. HCM is the most common inherited cardiac disorder affecting 1 in 250–500 people, yet few thera...

Full description

Bibliographic Details
Main Authors: Joshua A. Stern, Victor N. Rivas, Joanna L. Kaplan, Yu Ueda, Maureen S. Oldach, Eric S. Ontiveros, Kristina B. Kooiker, Sabine J. van Dijk, Samantha P. Harris
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-36932-5
_version_ 1797789772920389632
author Joshua A. Stern
Victor N. Rivas
Joanna L. Kaplan
Yu Ueda
Maureen S. Oldach
Eric S. Ontiveros
Kristina B. Kooiker
Sabine J. van Dijk
Samantha P. Harris
author_facet Joshua A. Stern
Victor N. Rivas
Joanna L. Kaplan
Yu Ueda
Maureen S. Oldach
Eric S. Ontiveros
Kristina B. Kooiker
Sabine J. van Dijk
Samantha P. Harris
author_sort Joshua A. Stern
collection DOAJ
description Abstract We sought to establish a large animal model of inherited hypertrophic cardiomyopathy (HCM) with sufficient disease severity and early penetrance for identification of novel therapeutic strategies. HCM is the most common inherited cardiac disorder affecting 1 in 250–500 people, yet few therapies for its treatment or prevention are available. A research colony of purpose-bred cats carrying the A31P mutation in MYBPC3 was founded using sperm from a single heterozygous male cat. Cardiac function in four generations was assessed by periodic echocardiography and measurement of blood biomarkers. Results showed that HCM penetrance was age-dependent, and that penetrance occurred earlier and was more severe in successive generations, especially in homozygotes. Homozygosity was also associated with progression from preclinical to clinical disease. A31P homozygous cats represent a heritable model of HCM with early disease penetrance and a severe phenotype necessary for interventional studies aimed at altering disease progression. The occurrence of a more severe phenotype in later generations of cats, and the occasional occurrence of HCM in wildtype cats suggests the presence of at least one gene modifier or a second causal variant in this research colony that exacerbates the HCM phenotype when inherited in combination with the A31P mutation.
first_indexed 2024-03-13T01:55:25Z
format Article
id doaj.art-5b4799ad46954d248634d5801bbc9c0c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-13T01:55:25Z
publishDate 2023-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5b4799ad46954d248634d5801bbc9c0c2023-07-02T11:14:15ZengNature PortfolioScientific Reports2045-23222023-06-0113111310.1038/s41598-023-36932-5Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-CJoshua A. Stern0Victor N. Rivas1Joanna L. Kaplan2Yu Ueda3Maureen S. Oldach4Eric S. Ontiveros5Kristina B. Kooiker6Sabine J. van Dijk7Samantha P. Harris8Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-DavisDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California-DavisDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California-DavisDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State UniversityVCA Sacramento Veterinary Referral CenterRady Children’s Institute for Genomic MedicineDivision of Cardiology, Department of Medicine, University of WashingtonDepartment of Neurobiology, Physiology, and Behavior, University of California-DavisDepartment of Neurobiology, Physiology, and Behavior, University of California-DavisAbstract We sought to establish a large animal model of inherited hypertrophic cardiomyopathy (HCM) with sufficient disease severity and early penetrance for identification of novel therapeutic strategies. HCM is the most common inherited cardiac disorder affecting 1 in 250–500 people, yet few therapies for its treatment or prevention are available. A research colony of purpose-bred cats carrying the A31P mutation in MYBPC3 was founded using sperm from a single heterozygous male cat. Cardiac function in four generations was assessed by periodic echocardiography and measurement of blood biomarkers. Results showed that HCM penetrance was age-dependent, and that penetrance occurred earlier and was more severe in successive generations, especially in homozygotes. Homozygosity was also associated with progression from preclinical to clinical disease. A31P homozygous cats represent a heritable model of HCM with early disease penetrance and a severe phenotype necessary for interventional studies aimed at altering disease progression. The occurrence of a more severe phenotype in later generations of cats, and the occasional occurrence of HCM in wildtype cats suggests the presence of at least one gene modifier or a second causal variant in this research colony that exacerbates the HCM phenotype when inherited in combination with the A31P mutation.https://doi.org/10.1038/s41598-023-36932-5
spellingShingle Joshua A. Stern
Victor N. Rivas
Joanna L. Kaplan
Yu Ueda
Maureen S. Oldach
Eric S. Ontiveros
Kristina B. Kooiker
Sabine J. van Dijk
Samantha P. Harris
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
Scientific Reports
title Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
title_full Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
title_fullStr Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
title_full_unstemmed Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
title_short Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
title_sort hypertrophic cardiomyopathy in purpose bred cats with the a31p mutation in cardiac myosin binding protein c
url https://doi.org/10.1038/s41598-023-36932-5
work_keys_str_mv AT joshuaastern hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT victornrivas hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT joannalkaplan hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT yuueda hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT maureensoldach hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT ericsontiveros hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT kristinabkooiker hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT sabinejvandijk hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc
AT samanthapharris hypertrophiccardiomyopathyinpurposebredcatswiththea31pmutationincardiacmyosinbindingproteinc